{"id":2294,"date":"2019-05-16T11:00:34","date_gmt":"2019-05-16T09:00:34","guid":{"rendered":"http:\/\/lupusgalicia.org\/?p=2294"},"modified":"2019-05-16T11:01:05","modified_gmt":"2019-05-16T09:01:05","slug":"la-fda-aprueba-el-uso-de-benlysta-para-ninos-y-adolescentes-con-lupus","status":"publish","type":"post","link":"https:\/\/lupusgalicia.org\/?p=2294","title":{"rendered":"La FDA aprueba el uso de Benlysta para ni\u00f1os y adolescentes con lupus"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Los ni\u00f1os y adolescentes que viven con lupus ahora pueden ser tratados con el uso intravenoso de Benlysta (belimumab), la \u00fanica terapia biol\u00f3gica desarrollada y aprobada especialmente para el lupus, ahora que la&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/gsk-receives-us-approval-of-benlysta-for-intravenous-use-in-children-with-lupus-aged-five-years-and-above\/\" target=\"_blank\">Administraci\u00f3n de Drogas y Alimentos (FDA) de EEUU ha aprobado<\/a>&nbsp;su uso en ni\u00f1os de tan solo cinco a\u00f1os a\u00f1os de edad.&nbsp;Benlysta ha sido aprobado para el tratamiento del lupus en adultos en 2011.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Esta aprobaci\u00f3n representa un gran avance para el tratamiento del lupus infantil, que puede ser m\u00e1s agresivo y grave que en los adultos.&nbsp;Los s\u00edntomas del lupus infantil son m\u00e1s intensos y la enfermedad puede tener efectos a largo plazo en el crecimiento, la calidad de vida de un ni\u00f1o y hasta el tiempo que viven.&nbsp;Se estima que hay hasta 10,000 ni\u00f1os con lupus en los Estados Unidos.&nbsp;Desconocemos cu\u00e1ntos en Espa\u00f1a.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Antes de esta aprobaci\u00f3n, los ni\u00f1os y adolescentes solo ten\u00edan acceso a medicamentos m\u00e1s antiguos y menos tolerables que se hab\u00edan desarrollado para otras enfermedades y nunca se hab\u00edan probado en ni\u00f1os para tratar el lupus.&nbsp;Las terapias como corticosteroides, antipal\u00fadicos y agentes inmunosupresores a menudo tienen consecuencias graves y debilitantes para la salud por el uso a largo plazo en adultos y m\u00e1s en ni\u00f1os.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Entre el 10 y el 20 por ciento de todos los casos de lupus se desarrollan durante la infancia.&nbsp;Las personas diagnosticadas en la infancia tienen m\u00e1s probabilidades de tener mayores tasas de da\u00f1o a los \u00f3rganos que las personas diagnosticadas como adultos.&nbsp;La Lupus Foundation of America reconoci\u00f3 estos desaf\u00edos y en 2006 estableci\u00f3 el primer y \u00fanico programa nacional de investigaci\u00f3n de lupus infantil, el Programa de Investigaci\u00f3n de Lupus Pedi\u00e1trico Michael Jon Barlin.&nbsp;Este programa apoya los descubrimientos en la investigaci\u00f3n de lupus infantil y ha financiado estudios importantes para desarrollar mejores formas de tratar y manejar el lupus en ni\u00f1os y adolescentes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Por ejemplo, la Dra. Kathleen Sullivan, Jefa de Divisi\u00f3n de Alergia e Inmunolog\u00eda del Hospital de Ni\u00f1os de Filadelfia, recibi\u00f3 fondos de la Fundaci\u00f3n para un estudio de cinco a\u00f1os para facilitar el desarrollo de herramientas de diagn\u00f3stico no invasivas para la nefritis l\u00fapica pedi\u00e1trica.&nbsp;Sullivan est\u00e1 trabajando para desarrollar una prueba simple que pueda medir la evaluaci\u00f3n en tiempo real de la actividad del lupus en los ni\u00f1os.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">En 2017, la Fundaci\u00f3n comenz\u00f3 una asociaci\u00f3n con la Alianza para la Investigaci\u00f3n de la Artritis y Reumatolog\u00eda Infantil (CARRA, por sus siglas en ingl\u00e9s) para reunir la defensa y la investigaci\u00f3n sobre el lupus infantil.&nbsp;El objetivo es identificar las \u00e1reas de mayor necesidad en la investigaci\u00f3n y el cuidado del lupus infantil y luego trabajar en colaboraci\u00f3n para llenar los vac\u00edos.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Obtenga m\u00e1s informaci\u00f3n sobre el&nbsp;<a href=\"https:\/\/www.lupus.org\/childhood-lupus\/our-childhood-lupus-research-program\">programa de investigaci\u00f3n de lupus infantil<\/a>&nbsp;.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Noticia original en<a href=\"https:\/\/www.lupus.org\/news\/breaking-news-fda-approves-use-of-benlysta-for-children-and-teens-with-lupus?utm_source=LO&amp;utm_medium=email&amp;utm_campaign=newsletter_2019-05\"> Lupus Foundation of America<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Los ni\u00f1os y adolescentes que viven con lupus ahora pueden ser tratados con el uso intravenoso de Benlysta (belimumab), la \u00fanica terapia biol\u00f3gica desarrollada y aprobada especialmente para el lupus, ahora que la&nbsp;Administraci\u00f3n de Drogas y Alimentos (FDA) de EEUU ha aprobado&nbsp;su uso en ni\u00f1os de tan solo cinco a\u00f1os a\u00f1os de edad.&nbsp;Benlysta ha sido [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2295,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[48,54,65],"class_list":["post-2294","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-benlysta","tag-lupus-foundation-of-america","tag-ninos-y-adolescentes"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\r\n<title>La FDA aprueba el uso de Benlysta para ni\u00f1os y adolescentes con lupus - Asociaci\u00f3n Galega de Lupus<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/lupusgalicia.org\/?p=2294\" \/>\r\n<meta property=\"og:locale\" content=\"es_ES\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"La FDA aprueba el uso de Benlysta para ni\u00f1os y adolescentes con lupus - Asociaci\u00f3n Galega de Lupus\" \/>\r\n<meta property=\"og:description\" content=\"Los ni\u00f1os y adolescentes que viven con lupus ahora pueden ser tratados con el uso intravenoso de Benlysta (belimumab), la \u00fanica terapia biol\u00f3gica desarrollada y aprobada especialmente para el lupus, ahora que la&nbsp;Administraci\u00f3n de Drogas y Alimentos (FDA) de EEUU ha aprobado&nbsp;su uso en ni\u00f1os de tan solo cinco a\u00f1os a\u00f1os de edad.&nbsp;Benlysta ha sido [&hellip;]\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/lupusgalicia.org\/?p=2294\" \/>\r\n<meta property=\"og:site_name\" content=\"Asociaci\u00f3n Galega de Lupus\" \/>\r\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LupusGalicia\/\" \/>\r\n<meta property=\"article:published_time\" content=\"2019-05-16T09:00:34+00:00\" \/>\r\n<meta property=\"article:modified_time\" content=\"2019-05-16T09:01:05+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2019\/05\/belimumab.jpg\" \/>\r\n\t<meta property=\"og:image:width\" content=\"1093\" \/>\r\n\t<meta property=\"og:image:height\" content=\"792\" \/>\r\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\r\n<meta name=\"author\" content=\"Agal\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:creator\" content=\"@LupusGalicia\" \/>\r\n<meta name=\"twitter:site\" content=\"@LupusGalicia\" \/>\r\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Agal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/lupusgalicia.org\/?p=2294#article\",\"isPartOf\":{\"@id\":\"https:\/\/lupusgalicia.org\/?p=2294\"},\"author\":{\"name\":\"Agal\",\"@id\":\"https:\/\/lupusgalicia.org\/#\/schema\/person\/4c5a48f33530bf5afca090219ff56665\"},\"headline\":\"La FDA aprueba el uso de Benlysta para ni\u00f1os y adolescentes con lupus\",\"datePublished\":\"2019-05-16T09:00:34+00:00\",\"dateModified\":\"2019-05-16T09:01:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/lupusgalicia.org\/?p=2294\"},\"wordCount\":540,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/lupusgalicia.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/lupusgalicia.org\/?p=2294#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2019\/05\/belimumab.jpg\",\"keywords\":[\"Benlysta\",\"Lupus Foundation of America\",\"ni\u00f1os y adolescentes\"],\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/lupusgalicia.org\/?p=2294#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/lupusgalicia.org\/?p=2294\",\"url\":\"https:\/\/lupusgalicia.org\/?p=2294\",\"name\":\"La FDA aprueba el uso de Benlysta para ni\u00f1os y adolescentes con lupus - Asociaci\u00f3n Galega de Lupus\",\"isPartOf\":{\"@id\":\"https:\/\/lupusgalicia.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/lupusgalicia.org\/?p=2294#primaryimage\"},\"image\":{\"@id\":\"https:\/\/lupusgalicia.org\/?p=2294#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2019\/05\/belimumab.jpg\",\"datePublished\":\"2019-05-16T09:00:34+00:00\",\"dateModified\":\"2019-05-16T09:01:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/lupusgalicia.org\/?p=2294#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/lupusgalicia.org\/?p=2294\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/lupusgalicia.org\/?p=2294#primaryimage\",\"url\":\"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2019\/05\/belimumab.jpg\",\"contentUrl\":\"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2019\/05\/belimumab.jpg\",\"width\":1093,\"height\":792},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/lupusgalicia.org\/?p=2294#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/lupusgalicia.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La FDA aprueba el uso de Benlysta para ni\u00f1os y adolescentes con lupus\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/lupusgalicia.org\/#website\",\"url\":\"https:\/\/lupusgalicia.org\/\",\"name\":\"Asociaci\u00f3n Galega de Lupus\",\"description\":\"Trabajando para y por las personas con Lupus\",\"publisher\":{\"@id\":\"https:\/\/lupusgalicia.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/lupusgalicia.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/lupusgalicia.org\/#organization\",\"name\":\"Asociaci\u00f3n Galega de Lupus\",\"url\":\"https:\/\/lupusgalicia.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/lupusgalicia.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2023\/06\/AGAL-scaled.png\",\"contentUrl\":\"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2023\/06\/AGAL-scaled.png\",\"width\":2560,\"height\":2522,\"caption\":\"Asociaci\u00f3n Galega de Lupus\"},\"image\":{\"@id\":\"https:\/\/lupusgalicia.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LupusGalicia\/\",\"https:\/\/x.com\/LupusGalicia\",\"https:\/\/www.instagram.com\/lupusgalicia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/lupusgalicia.org\/#\/schema\/person\/4c5a48f33530bf5afca090219ff56665\",\"name\":\"Agal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/7f60df48bf4a5a797270581c89811177b4ff71b18f397a910784a9bfc7025e33?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7f60df48bf4a5a797270581c89811177b4ff71b18f397a910784a9bfc7025e33?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7f60df48bf4a5a797270581c89811177b4ff71b18f397a910784a9bfc7025e33?s=96&d=mm&r=g\",\"caption\":\"Agal\"},\"description\":\"AGAL. Asociaci\u00f3n Galega de Lupus. Creada en 1997. Pretendemos dar informaci\u00f3n sobre el Lupus y que la enfermedad deje de ser una gran desconocida; ayudar a familiares y amigos; promover investigaci\u00f3n; divulgar y relacionar a nuestros asociados a trav\u00e9s de Jornadas, la revista Papilio, charlas, reuniones...\",\"sameAs\":[\"http:\/\/www.lupusgalicia.org\"],\"url\":\"https:\/\/lupusgalicia.org\/?author=1\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La FDA aprueba el uso de Benlysta para ni\u00f1os y adolescentes con lupus - Asociaci\u00f3n Galega de Lupus","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lupusgalicia.org\/?p=2294","og_locale":"es_ES","og_type":"article","og_title":"La FDA aprueba el uso de Benlysta para ni\u00f1os y adolescentes con lupus - Asociaci\u00f3n Galega de Lupus","og_description":"Los ni\u00f1os y adolescentes que viven con lupus ahora pueden ser tratados con el uso intravenoso de Benlysta (belimumab), la \u00fanica terapia biol\u00f3gica desarrollada y aprobada especialmente para el lupus, ahora que la&nbsp;Administraci\u00f3n de Drogas y Alimentos (FDA) de EEUU ha aprobado&nbsp;su uso en ni\u00f1os de tan solo cinco a\u00f1os a\u00f1os de edad.&nbsp;Benlysta ha sido [&hellip;]","og_url":"https:\/\/lupusgalicia.org\/?p=2294","og_site_name":"Asociaci\u00f3n Galega de Lupus","article_publisher":"https:\/\/www.facebook.com\/LupusGalicia\/","article_published_time":"2019-05-16T09:00:34+00:00","article_modified_time":"2019-05-16T09:01:05+00:00","og_image":[{"width":1093,"height":792,"url":"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2019\/05\/belimumab.jpg","type":"image\/jpeg"}],"author":"Agal","twitter_card":"summary_large_image","twitter_creator":"@LupusGalicia","twitter_site":"@LupusGalicia","twitter_misc":{"Escrito por":"Agal","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lupusgalicia.org\/?p=2294#article","isPartOf":{"@id":"https:\/\/lupusgalicia.org\/?p=2294"},"author":{"name":"Agal","@id":"https:\/\/lupusgalicia.org\/#\/schema\/person\/4c5a48f33530bf5afca090219ff56665"},"headline":"La FDA aprueba el uso de Benlysta para ni\u00f1os y adolescentes con lupus","datePublished":"2019-05-16T09:00:34+00:00","dateModified":"2019-05-16T09:01:05+00:00","mainEntityOfPage":{"@id":"https:\/\/lupusgalicia.org\/?p=2294"},"wordCount":540,"commentCount":0,"publisher":{"@id":"https:\/\/lupusgalicia.org\/#organization"},"image":{"@id":"https:\/\/lupusgalicia.org\/?p=2294#primaryimage"},"thumbnailUrl":"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2019\/05\/belimumab.jpg","keywords":["Benlysta","Lupus Foundation of America","ni\u00f1os y adolescentes"],"articleSection":["Uncategorized"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/lupusgalicia.org\/?p=2294#respond"]}]},{"@type":"WebPage","@id":"https:\/\/lupusgalicia.org\/?p=2294","url":"https:\/\/lupusgalicia.org\/?p=2294","name":"La FDA aprueba el uso de Benlysta para ni\u00f1os y adolescentes con lupus - Asociaci\u00f3n Galega de Lupus","isPartOf":{"@id":"https:\/\/lupusgalicia.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lupusgalicia.org\/?p=2294#primaryimage"},"image":{"@id":"https:\/\/lupusgalicia.org\/?p=2294#primaryimage"},"thumbnailUrl":"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2019\/05\/belimumab.jpg","datePublished":"2019-05-16T09:00:34+00:00","dateModified":"2019-05-16T09:01:05+00:00","breadcrumb":{"@id":"https:\/\/lupusgalicia.org\/?p=2294#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lupusgalicia.org\/?p=2294"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/lupusgalicia.org\/?p=2294#primaryimage","url":"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2019\/05\/belimumab.jpg","contentUrl":"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2019\/05\/belimumab.jpg","width":1093,"height":792},{"@type":"BreadcrumbList","@id":"https:\/\/lupusgalicia.org\/?p=2294#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/lupusgalicia.org\/"},{"@type":"ListItem","position":2,"name":"La FDA aprueba el uso de Benlysta para ni\u00f1os y adolescentes con lupus"}]},{"@type":"WebSite","@id":"https:\/\/lupusgalicia.org\/#website","url":"https:\/\/lupusgalicia.org\/","name":"Asociaci\u00f3n Galega de Lupus","description":"Trabajando para y por las personas con Lupus","publisher":{"@id":"https:\/\/lupusgalicia.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lupusgalicia.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/lupusgalicia.org\/#organization","name":"Asociaci\u00f3n Galega de Lupus","url":"https:\/\/lupusgalicia.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/lupusgalicia.org\/#\/schema\/logo\/image\/","url":"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2023\/06\/AGAL-scaled.png","contentUrl":"https:\/\/lupusgalicia.org\/wp-content\/uploads\/2023\/06\/AGAL-scaled.png","width":2560,"height":2522,"caption":"Asociaci\u00f3n Galega de Lupus"},"image":{"@id":"https:\/\/lupusgalicia.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LupusGalicia\/","https:\/\/x.com\/LupusGalicia","https:\/\/www.instagram.com\/lupusgalicia\/"]},{"@type":"Person","@id":"https:\/\/lupusgalicia.org\/#\/schema\/person\/4c5a48f33530bf5afca090219ff56665","name":"Agal","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/7f60df48bf4a5a797270581c89811177b4ff71b18f397a910784a9bfc7025e33?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7f60df48bf4a5a797270581c89811177b4ff71b18f397a910784a9bfc7025e33?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7f60df48bf4a5a797270581c89811177b4ff71b18f397a910784a9bfc7025e33?s=96&d=mm&r=g","caption":"Agal"},"description":"AGAL. Asociaci\u00f3n Galega de Lupus. Creada en 1997. Pretendemos dar informaci\u00f3n sobre el Lupus y que la enfermedad deje de ser una gran desconocida; ayudar a familiares y amigos; promover investigaci\u00f3n; divulgar y relacionar a nuestros asociados a trav\u00e9s de Jornadas, la revista Papilio, charlas, reuniones...","sameAs":["http:\/\/www.lupusgalicia.org"],"url":"https:\/\/lupusgalicia.org\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=\/wp\/v2\/posts\/2294","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2294"}],"version-history":[{"count":2,"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=\/wp\/v2\/posts\/2294\/revisions"}],"predecessor-version":[{"id":2297,"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=\/wp\/v2\/posts\/2294\/revisions\/2297"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=\/wp\/v2\/media\/2295"}],"wp:attachment":[{"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2294"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2294"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lupusgalicia.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}